Terry A. Jacobson

Emory University — United States

Medicine · Health Sciences

82h-index28.1kcitations300works21.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(180), Diabetes, Cardiovascular Risks, and Lipoproteins(75), Health Systems, Economic Evaluations, Quality of Life(56), Fatty Acid Research and Health(47), Pharmaceutical Economics and Policy(34)

Publications299 total

Cardiovascular Outcomes with Icosapent Ethyl by Burden of Standard Modifiable Cardiovascular Risk Factors in REDUCE-IT
American Journal of Preventive Cardiology·2026Open Access
Distribution of coronary artery calcium volume and density by age, sex, and race using AI-based quantification algorithm
Journal of cardiovascular computed tomography·2026
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM
American Journal of Preventive Cardiology·2025Open Access
Abstract 4370601: Efficacy of Icosapent Ethyl for Cardiovascular Risk Reduction by Aspirin Use in REDUCE-IT
Circulation·2025
Benefit of icosapent ethyl across types and sizes of myocardial infarction in REDUCE-IT
European Journal of Preventive Cardiology·2025· 1 citedOpen Access
Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease
JACC Advances·2025· 2 citedOpen Access
O-170 Revolutionizing Fertility Nursing: AI-Powered Patient Support with CHARLI
Human Reproduction·2025Open Access
Prevalence and Correlates of Lipoprotein(a) Testing in a Diverse Cohort of U.S. Adults
JACC Advances·2025· 7 citedOpen Access
Managing Hypercholesterolemia in Adults Older Than 75 years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus From the National Lipid Association and the American Geriatrics Society
Journal of the American Geriatrics Society·2025· 6 citedOpen Access
Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics Society
Journal of clinical lipidology·2025· 13 citedOpen Access
Statin-Associated Muscle Symptoms: Identification and Recommendations for Management
Current Atherosclerosis Reports·2024· 7 cited
Abstract 4140394: Substantial cardiovascular risk reduction with icosapent ethyl in patients with prior cardiovascular events regardless of coronary artery disease history: REDUCE-IT CAD
Circulation·2024
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
Journal of clinical lipidology·2024· 55 citedOpen Access
Significant Reduction in ST-Elevation MI With Icosapent Ethyl in REDUCE-IT
Heart Lung and Circulation·2024Open Access
Optimizing Residual Cardiovascular Risk in a Case of Homozygous Familial Hypercholesterolemia (HoFH) and Elevated Lipoprotein (a) [Lp(a)]
Journal of clinical lipidology·2024
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Journal of clinical lipidology·2024· 90 citedOpen Access
EFFICACY OF ICOSAPENT ETHYL FOR REDUCING CARDIOVASCULAR OUTCOMES BY BASELINE LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL
Journal of the American College of Cardiology·2024
A CASE REPORT OF FAMILIAL HYPERCHOLESTEROLEMIA WITH UNPRECEDENTED RESPONSE TO PLASMAPHERESIS
Journal of the American College of Cardiology·2024
ICOSAPENT ETHYL REDUCES MACE IN PATIENTS WITH ELEVATED TRIGLYCERIDES AND HIGH OR LOW LIPOPROTEIN(A) CONCENTRATIONS: A REDUCE-IT SUBANALYSIS
Journal of the American College of Cardiology·2024· 1 cited
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
Journal of clinical lipidology·2024· 221 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Eliot A. Brinton(9), Kevin C. Maki(7), Sunil Kripalani(7), Michael Miller(6), Christie M. Ballantyne(6), James M. McKenney(6), Éric Bruckert(5), Carl E. Orringer(5), Don P. Wilson(5), Scott M. Grundy(5), Matthew K. Ito(5), Charles R. Harper(5), Alberto Corsini(4), Evan A. Stein(4), Børge G. Nordestgaard(4), Winfried März(4), M. John Chapman(4), Henry N. Ginsberg(4), Robert A. Wild(4), Harold Bays(4)